EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Outcomes and mortality risk scoring for infections caused by carbapenem-resistant Escherichia coli and Klebsiella pneumoniae

Jack El Sawda, Jawan Abdulrahim, Rayyan Wazzi Mkahal, George Doumat, Tamara Nawar, Antoine Saliba, Souha S Kanj, Zeina A Kanafani

The Journal of Infection in Developing Countries · 2025

DOI: 10.3855/jidc.20725 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Jack El Sawda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Washington University School of Medicine in St. Louis, St. Louis, MO, United States. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Carbapenem-Resistant Enterobacteriaceae, Anti-Bacterial Agents. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Carbapenem-resistant Enterobacterales (CRE) are becoming increasingly prevalent and have been associated with increased mortality. Due to the paucity of data from the region, we evaluated the risk factors and outcomes of infections caused by CRE at a tertiary care center in Lebanon. Methodology: The study had three arms in a case-case-control design: patients with CRE infections, patients with infections due to ceftriaxone-resistant carbapenem-susceptible Enterobacterales (CSE), and uninfected controls (UC). Logistic regression was performed to identify risk factors uniquely associated with CRE. A CRE infection score was also created to assess the likelihood of having a CRE infection.

Results

We included 337 patients (112 CRE, 75 CSE, 150 UC). Predictors unique to CRE infection included recent surgery (Odds Ratio (OR) 25.7; 95% confidence interval (CI95 5.7-115.2), carbapenem use within 30 days (OR 19.1; CI95 3.3-109.6), and malignancy (OR 4.2; CI95 1.6-10.5). The mean CRE score was 4.2 ± 2.2 in the CRE group and 2.4 ± 2.4 in the CSE group (p < 0.001). Infection-related mortality was higher among CRE patients (63.6% vs. 20.0%; p = 0.015), and CRE was independently associated with all-cause in-hospital mortality.

Conclusions

We developed a scoring system that would allow risk stratification and would guide empiric antibiotic therapy. CRE infections were associated with a worse outcome compared to CSE infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeKlebsiella InfectionsCarbapenem-Resistant EnterobacteriaceaeAnti-Bacterial AgentsEscherichia coli InfectionsCarbapenemsEscherichia coliHumansMaleFemaleCase-Control StudiesMiddle AgedAgedLebanonRisk FactorsTertiary Care CentersAdultAged, 80 and overTreatment OutcomeRisk Assessment

Stichwörter der Autor:innen

Carbapenem resistanceEnterobacteralesrisk stratification

Substanzen

Anti-Bacterial AgentsCarbapenems

Autor:innen und Institutionen

  • Washington University School of Medicine in St. Louis, St. Louis, MO, United States.
  • Duke University, Durham, NC, United States.
  • American University of Beirut, Beirut, Lebanon.
  • Harvard Medical School, Boston, MA, United States.
  • Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Mayo Clinic, Rochester, MN, United States.

Zitieren

APA

El Sawda, J., Abdulrahim, J., Mkahal, R. W., Doumat, G., Nawar, T., Saliba, A., Kanj, S. S., & Kanafani, Z. A. (2025). Outcomes and mortality risk scoring for infections caused by carbapenem-resistant Escherichia coli and Klebsiella pneumoniae. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.20725

Vancouver

El Sawda J, Abdulrahim J, Mkahal RW, Doumat G, Nawar T, Saliba A, et al. Outcomes and mortality risk scoring for infections caused by carbapenem-resistant Escherichia coli and Klebsiella pneumoniae. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.20725

BibTeX
@article{ElSawda2025,
  author = {El Sawda, Jack and Abdulrahim, Jawan and Mkahal, Rayyan Wazzi and Doumat, George and Nawar, Tamara and Saliba, Antoine and Kanj, Souha S and Kanafani, Zeina A},
  title = {Outcomes and mortality risk scoring for infections caused by carbapenem-resistant Escherichia coli and Klebsiella pneumoniae},
  journal = {The Journal of Infection in Developing Countries},
  year = {2025},
  doi = {10.3855/jidc.20725}
}
Kostenlos starten →